I n recent years, significant effort has been devoted to develop nanotechnology for the delivery of small molecular weight drugs, as well as macromolecules such as proteins, peptides, or genes into cells and tissue. [1] [2] [3] [4] [5] [6] [7] Targeted nanoparticle-mediated drug delivery may be used to direct the particles to specific tissues (minimizing toxicity), improve oral bioavailability, sustain drug/gene effect in the target tissue, solubilize drugs for intravascular delivery, and/or improve the stability of therapeutic agents against enzymatic degradation.
8 Despite the fantastic potential for nanoparticle use in medicine, fundamental studies to understand the molecular interactions of nanoparticles with their target cells (normal as well as malignant) remain largely unexplored. One such mechanism of action may be ionic interactions; the negative membrane potential of most cells likely interacts differently with nanoparticles of a positive versus negative charge density. These interactions could, in turn, determine intracellular uptake and localization of the nanoparticles and their biological functions. Understanding such interactions between cells and nanoparticles with different surface properties is important not only for engineering of nanoparticles that exhibit selective intracellular uptake (to subsequently modulate cellular processes of interest) but also for determining the relative cytotoxicity of nanoparticles.
All living cells have an inherent membrane potential that is determined by ionic permeability and modulated by processes including electrical or agonist stimulation, ion channels, and changes in intracellular versus extracellular ionic concentrations. Furthermore, the membrane potential itself can modulate a number of intracellular pathways, including intracellular Ca 2+ concentration ([Ca 2+ ] i ), the cell cycle, and cellular proliferation versus apoptosis; each important not only for normal cell structure and function but also in the progression of diseases, especially cancer. 9, 10 Additionally, changes in [Ca 2+ ] i induced by altered membrane potential or by other mechanisms serves to regulate cell growth. Accordingly, if nanoparticles are to realize their potential in biomedical applications it is important to determine the nature of their interactions with cells (particularly the plasma membrane), and their concomitant modulation of subsequent signaling pathways (especially [Ca 2+ ] i regulation). We address here these important issues in nanoparticle biology by testing the hypothesis that membrane potential is a key player in determining intracellular uptake of nanoparticles. Using both malignant cells (ovarian cancer CP70 and A2780 cells) and nonmalignant, excitable cells (human bronchial epithelial cells (BECs) and human airway smooth muscle (ASM) cells), we investigated whether cellular membrane potential plays a role in uptake of gold nanoparticles (AuNPs) of different charges (positive, To assess the role of surface charge of nanoparticles on membrane potential, we synthesized AuNPs (∼2 nm core size) using the Brust-Schiffrin two-phase synthesis method. A2780, BEC, 15 and ASM 16 cells loaded with the fluorescent, fast-response membrane potential-sensitive dye RH414. The baseline plasma membrane potential ranged between -75 and -55 mV depending on cell type. With images taken at 1-2 frames/s, fluorescence levels remained stable for at least 5 min in vehicle controls. 16 Among the four species of AuNPs, only + AuNPs induced membrane depolarization across different cell types ( Figure 1B ). In comparison, membrane depolarization induced by -AuNP, 0 AuNP or ( AuNP was negligible ( Figure 1B , also see Supporting Information Figure S1 ). The extent of membrane depolarization was found to be dependent on + AuNP concentration ( Figure 1C ; p < 0.05 compared to vehicle control) with minimal depolarization at 10 nM, and substantial depolarization at 1.2 µM + AuNP in less than 10 s with maximum depolarization reached in ∼5 min across cell types (Supporting Information Figure S1 ). Among cell types, the extent of depolarization was greatest in ovarian cancer cells (CP70, A2780) and comparable to that achieved with 40 mM KCl (which produces a depolarization to ∼-25 mV) ( Figure 1B , and Supporting Information Figure S1 ). We verified lack of fluorescence quenching by examining the effect of AuNPs on RH414 fluorescence in an in vitro acellular preparation (not shown).
Next, we wanted to investigate the factors that determined intracellular uptake of AuNPs, focusing on membrane potential. In CP70, A2780, BEC, and ASM cells, uptake of + AuNPs (as determined by INAA 17 ) was significantly higher than AuNPs of other charges (Figure 2A ; p < 0.05). However, prior depolarization of the plasma membrane using 40 or 80 mM KCl (which changed membrane potential to ∼-25 and ∼-8 mV, respectively) resulted in significant reduction in the extent of + AuNP uptake in all cell types ( Figure 2B ; p < 0.05). Furthermore, in cells pre-exposed to KCl, the extent of membrane depolarization induced by 1.2 µM + AuNPs was significantly smaller, confirming the inability of these particles to depolarize the membrane under these conditions ( Figure 2C ; p < 0.05). In summary, these data clearly demonstrate a key role for membrane potential in intracellular uptake of AuNPs. Furthermore, by altering membrane potential, AuNPs may modulate their own uptake.
In most cells, membrane depolarization leads to increases in [Ca 2+ ] i that can result in further modulation of cellular events (such as proliferation vs apoptosis). 9, 18 To test whether such membrane depolarization by + AuNPs and their intracellular uptake had any effect on intracellular signaling events, we first determined changes in [Ca 2+ ] i . In CP70, Figure 3A ). Some cells displayed an initial higher [Ca 2+ ], followed by a decay to a lower level above baseline (Supporting Information Figure S2 ). Addition of AuNPs of other surface charges produced negligible changes in [Ca 2+ ] i levels ( Figure 3A ,B and Supporting Information Figure S2 ). In control experiments, each of these cell types were exposed to 40 mM KCl, which produced [Ca 2+ ] i elevations across cell types albeit with different time delays and profiles (Supporting Information Figure S2 ). The extent of change in [Ca 2+ ] i was concentration-dependent with significant changes observed even at 10 nM + AuNPs ( Figure  3C ; p < 0.05). As with RH414, lack of fura-2 quenching by AuNPs was verified using the cell-impermeant pentapotassium form of fura-2 (not shown).
To ] i with the relative contribution of plasma membrane versus intracellular mechanisms differing between cell types. 19, 20 Indeed, it is now recognized that a number of disease states involve dysregulation of this universal intracellular messenger, modulating cellular proliferation versus apoptosis (as in cancers and other proliferative diseases), cellular contraction (as in asthma and other reactive airway diseases), and fibrosis. concentrations), 19 + AuNPs completely inhibited proliferation (determined by 3 H-thymidine incorporation 4 ) of BECs, whereas proliferation of CP70 and A2780 cells remained largely unaffected ( Figure 4A ; p > 0.05). Furthermore, apoptosis (determined using annexin-propidium iodide assay) was only slightly increased in CP70 cells following + AuNP exposure ( Figure 4B ). In contrast, BEC cells displayed substantial apoptosis ( Figure 4B ; p < 0.05). Indeed, cellular viability (determined by an MTS assay) of normal BEC and ASM cells was substantially reduced by + AuNP exposure ( Figure 4C ; p < 0.05). To determine whether these changes in cellular proliferation and apoptosis were a result of Figure S3 , compare to Figure 4) . Furthermore, unlike + AuNPs, KCl had negligible effects on apoptosis of ASM cells. In all of these experiments, it must be noted that the duration of AuNP (or KCl) exposure was brief (minutes), while apoptosis or proliferation was evaluated after ∼24 h (overnight). Accordingly, these changes are unlikely to reflect short-term cell death resulting from cytotoxicity of AuNPs. ] i , but additional effects on signaling pathways. Accordingly, an important aspect of understanding AuNP action may be identifying different signaling mechanisms that may be targeted by AuNPs, with normal versus cancer cells being differently sensitive to alterations in these mechanisms (especially relating to apoptosis and proliferation).
In conclusion, we have demonstrated that cellular membrane potential plays a prominent role in intracellular uptake of AuNPs. Perturbation of the membrane potential is dependent on surface charge of the nanoparticles; positively charged nanoparticles depolarize the membrane to the greatest extent with nanoparticles of other charges having negligible effect. Such membrane potential perturbations result in increased [Ca 2+ ] i , which in turn inhibits the proliferation of normal cells whereas malignant cells remain unaffected. The mechanisms by which positively charged nanoparticles interact with the plasma membrane need to be further investigated. Such interactions may involve AuNPs binding to the plasma membrane. Indeed, this was found using transmission electron microscopy 25 (TEM) where nanoparticles were clearly seen to be bound to the cell membrane (Figures 5A, left panels are the low magnification images, right panels being the higher magnification images of the corresponding left panels). Once bound to the plasma membrane, an obvious question is whether AuNPs disrupt the membrane, potentially resulting in depolarization and Ca 2+ influx. However, TEM studies did not demonstrate any membrane disruption ( Figure 5A ). One plausible mechanism for AuNP action is the flipping of membrane areas by these particles. Uptake may also involve lipid rafts, pinocytosis and other plasma membrane mechanisms. Indeed, previous studies have found that modulation of nanoparticle surface properties can influence the mechanism of intracellular uptake (i.e., endosomal, passive diffusion). [26] [27] [28] However, the extremely fast membrane depolarization and rapid uptake of AuNPs that was observed in our study need to be reconciled with the relatively slow rate of such uptake processes. Regardless, the findings of the present study will help to better define the biology of cell-nanoparticle interactions and help engineer nanoparticles to modulate cellular functions of interest. For example, varying surface charge density or combining positive and negative charges on the same nanoparticle may allow for graduated cellular uptake, targeting toward specific intracellular organelles, as well as control of the extent of change in [Ca 2+ ] i and other effects, thus balanced unintended cytotoxicity versus targeting mechanisms of interest.
